Jared Kaltwasser

Patients who saw hair specialist dermatologists tended to be prescribed more therapies for their scarring alopecia.

Previous inquiries into the associations between sleep disorders were limited by small sample sizes, according to researchers.

A new review explains how new therapies and technologies are guiding the treatment of acute myeloid leukemia (AML).

Delgocitinib led to notable improvement by week 4, which may have helped improve longer-term treatment adherence.

The benefits of exercise are particularly notable for patients who are dependent upon dialysis, a new review suggests.

Chimeric antigen receptor-based immunotherapies show promise when directed at viral targets, but data are limited.

Many MASH cirrhosis trials use histologic endpoints, but a new review finds limited standardization of these outcomes across studies.

A consensus definition of high genomic complexity in chronic lymphocytic leukemia may be less important than analyzing the contributions of individual biomarkers.

The investigational drug for late-stage MASH will now get more robust, proactive guidance from U.S. and European regulators.

Large language models are sure-footed at supplying answers, but what happens in medical contexts when that certainty can be a liability?